Lazard Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $102M | Buy |
|
|||||
|
2025
Q2 | $78.7M | Sell |
|
|||||
|
2025
Q1 | $83M | Buy |
|
|||||
|
2024
Q4 | $60.2M | Sell |
|
|||||
|
2024
Q3 | $90.4M | Sell |
|
|||||
|
2024
Q2 | $150M | Buy |
|
|||||
|
2024
Q1 | $32.7M | Buy |
|
|||||
|
2023
Q4 | $23.8M | Buy |
|
|||||
|
2023
Q3 | $19.2M | Buy |
|
|||||
|
2023
Q2 | $11.4M | Buy |
|
|||||
|
2023
Q1 | $7.57M | Buy |
|
|||||
|
2022
Q4 | $260K | Buy |
|
|||||
|
2022
Q3 | $183K | Hold |
|
|||||
|
2022
Q2 | $221K | Sell |
|
|||||
|
2022
Q1 | $246K | Sell |
|
|||||
|
2021
Q4 | $3.36M | Sell |
|
|||||
|
2021
Q3 | $48.8M | Buy |
|
|||||
|
2021
Q2 | $10.6M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $10K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $2K | Buy |
|